Nordic Nanovector ASA ( (DE:8NN) ) has issued an announcement.
AG Thor Medical, a shareholder group led by Jon Magne Asmyr, has secured significant voting power in Thor Medical ASA, controlling 10.37% of the total outstanding shares. The group aims to influence board composition and ensure representation to manage shareholder values effectively ahead of the General Meeting on April 24, 2025.
More about Nordic Nanovector ASA
YTD Price Performance: -16.82%
Average Trading Volume: 8,712
Technical Sentiment Signal: Buy
Current Market Cap: €60.9M
Find detailed analytics on 8NN stock on TipRanks’ Stock Analysis page.